• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人核心蛋白聚糖结构域I作为具有20 kDa糖胺聚糖链的重组硫酸乙酰肝素蛋白聚糖的表达。

Expression of human perlecan domain I as a recombinant heparan sulfate proteoglycan with 20-kDa glycosaminoglycan chains.

作者信息

Graham L D, Whitelock J M, Underwood P A

机构信息

CSIRO Molecular Science, Sydney Laboratory, North Ryde, New South Wales, 1670, Australia.

出版信息

Biochem Biophys Res Commun. 1999 Mar 24;256(3):542-8. doi: 10.1006/bbrc.1999.0377.

DOI:10.1006/bbrc.1999.0377
PMID:10080934
Abstract

Recombinant forms of human perlecan domain I were secreted as proteoglycans by stably transfected human 293 cells. A recombinant domain I-only proteoglycan spanned the 95- to 265-kDa region in SDS-PAGE and appeared to be 160 kDa in denaturing gel filtration. Its glycosaminoglycan (GAG) content was approximately 67% heparan sulfate, and its average GAG chain size of 20 kDa suggested that the true molecular mass of the proteoglycan was 90 kDa. Domain I with enhanced green fluorescent protein fused to its C-terminus had an apparent molecular mass of 210-220 kDa and contained approximately 100% heparan sulfate. Its average GAG chain size (also 20 kDa) suggested a true molecular mass of 117 kDa for this proteoglycan. Its sulfate content of 53-77 mol SO2-4 per mole of protein indicated the presence of one sulfate group per 4-7 GAG sugar residues.

摘要

人核心蛋白聚糖结构域I的重组形式由稳定转染的人293细胞作为蛋白聚糖分泌。一种仅含结构域I的重组蛋白聚糖在SDS-PAGE中跨越95至265 kDa区域,在变性凝胶过滤中似乎为160 kDa。其糖胺聚糖(GAG)含量约为67%硫酸乙酰肝素,其平均GAG链大小为20 kDa,表明该蛋白聚糖的真实分子量为90 kDa。在其C末端融合了增强型绿色荧光蛋白的结构域I的表观分子量为210 - 220 kDa,且含有约100%硫酸乙酰肝素。其平均GAG链大小(同样为20 kDa)表明该蛋白聚糖的真实分子量为117 kDa。其每摩尔蛋白质的硫酸盐含量为53 - 77摩尔SO2-4,表明每4 - 7个GAG糖残基存在一个硫酸基团。

相似文献

1
Expression of human perlecan domain I as a recombinant heparan sulfate proteoglycan with 20-kDa glycosaminoglycan chains.人核心蛋白聚糖结构域I作为具有20 kDa糖胺聚糖链的重组硫酸乙酰肝素蛋白聚糖的表达。
Biochem Biophys Res Commun. 1999 Mar 24;256(3):542-8. doi: 10.1006/bbrc.1999.0377.
2
Characterization of proteoglycans synthesized by murine embryonal carcinoma cells (P19) reveals increased expression of perlecan (heparan sulfate proteoglycan) during neuronal differentiation.对小鼠胚胎癌细胞(P19)合成的蛋白聚糖的表征显示,在神经元分化过程中,基底膜聚糖(硫酸乙酰肝素蛋白聚糖)的表达增加。
J Neurosci Res. 1994 Aug 15;38(6):670-86. doi: 10.1002/jnr.490380610.
3
Formation of heparan sulfate or chondroitin/dermatan sulfate on recombinant domain I of mouse perlecan expressed in Chinese hamster ovary cells.在中国仓鼠卵巢细胞中表达的小鼠基底膜聚糖重组结构域I上硫酸乙酰肝素或硫酸软骨素/硫酸皮肤素的形成。
Biochem Biophys Res Commun. 1995 Jun 6;211(1):262-7. doi: 10.1006/bbrc.1995.1805.
4
Localization of glycosaminoglycan substitution sites on domain V of mouse perlecan.小鼠基底膜聚糖结构域V上糖胺聚糖取代位点的定位
Biochem Biophys Res Commun. 1999 Nov 30;265(3):680-90. doi: 10.1006/bbrc.1999.1714.
5
Perlecan is responsible for thrombospondin 1 binding on the cell surface of cultured porcine endothelial cells.基底膜聚糖负责血小板反应蛋白1在培养的猪内皮细胞表面的结合。
Eur J Cell Biol. 1997 Aug;73(4):332-43.
6
Expression of the basement membrane heparan sulfate proteoglycan (perlecan) in human synovium and in cultured human synovial cells.基底膜硫酸乙酰肝素蛋白聚糖(核心蛋白聚糖)在人滑膜及培养的人滑膜细胞中的表达。
Lab Invest. 1995 Nov;73(5):649-57.
7
Isolation and characterization of proteoglycans from human follicular fluid.人卵泡液中蛋白聚糖的分离与鉴定
Biochem J. 1999 Jun 15;340 ( Pt 3)(Pt 3):613-20.
8
Structural basis of glycosaminoglycan modification and of heterotypic interactions of perlecan domain V.硫酸乙酰肝素修饰及基底膜聚糖结构域V异型相互作用的结构基础
J Mol Biol. 1999 Nov 19;294(1):259-70. doi: 10.1006/jmbi.1999.3259.
9
Analysis of glycosaminoglycan chains from different proteoglycan populations in human embryonic skin fibroblasts.人胚胎皮肤成纤维细胞中不同蛋白聚糖群体的糖胺聚糖链分析
Eur J Biochem. 1992 Sep 1;208(2):537-46. doi: 10.1111/j.1432-1033.1992.tb17218.x.
10
Differentially expressed patterns of glycosaminoglycan structure in heparan sulfate proteoglycans and free chains.硫酸乙酰肝素蛋白聚糖和游离链中糖胺聚糖结构的差异表达模式。
Eur J Biochem. 1993 Feb 1;211(3):771-9. doi: 10.1111/j.1432-1033.1993.tb17608.x.

引用本文的文献

1
A Novel Pathogenic Mutation in Schwartz-Jampel Syndrome.施瓦茨-扬佩尔综合征中的一种新型致病突变。
Front Neurol. 2021 Mar 9;12:632336. doi: 10.3389/fneur.2021.632336. eCollection 2021.
2
Review of Alterations in Perlecan-Associated Vascular Risk Factors in Dementia.痴呆症中与基底膜硫酸乙酰肝素蛋白多糖相关的血管危险因素的改变综述。
Int J Mol Sci. 2020 Jan 20;21(2):679. doi: 10.3390/ijms21020679.
3
Modular Proteoglycan Perlecan/: Mutations, Phenotypes, and Functions.模块化蛋白聚糖基底膜聚糖:突变、表型与功能
Genes (Basel). 2018 Nov 16;9(11):556. doi: 10.3390/genes9110556.
4
Can we produce heparin/heparan sulfate biomimetics using "mother-nature" as the gold standard?我们能否以“大自然”为金标准来生产肝素/硫酸乙酰肝素仿生材料?
Molecules. 2015 Mar 5;20(3):4254-76. doi: 10.3390/molecules20034254.
5
Similarity of recombinant human perlecan domain 1 by alternative expression systems bioactive heterogenous recombinant human perlecan D1.不同表达系统表达的重组人基膜聚糖域 1 类似物的生物活性异源重组人基膜聚糖 D1
BMC Biotechnol. 2010 Sep 9;10:66. doi: 10.1186/1472-6750-10-66.
6
Perlecan and tumor angiogenesis.基底膜聚糖与肿瘤血管生成
J Histochem Cytochem. 2003 Nov;51(11):1393-410. doi: 10.1177/002215540305101101.